Evrard A, Cuq P, Ciccolini J, Vian L, Cano J P
Laboratoire de Toxicologie du Médicament, Faculté de Pharmacie, Montpellier, France.
Br J Cancer. 1999 Aug;80(11):1726-33. doi: 10.1038/sj.bjc.6690589.
5-Fluorouracil (5-FU) and 5'-deoxy-5-fluorouridine (5'-DFUR), a prodrug of 5-FU, are anticancer agents activated by thymidine phosphorylase (TP). Transfecting the human TP cDNA into cancer cells in order to sensitize them to these pyrimidine antimetabolites may be an important approach in human cancer gene therapy research. In this study, an expression vector containing the human TP cDNA (pcTP5) was transfected into LS174T human colon carcinoma cells. Eight stable transfectants were randomly selected and analysed. The cytotoxic effects of 5-FU and 5'-DFUR were higher in TP-transfected cells as compared to wild-type cells. The maximal decreases in the IC50 were 80-fold for 5-FU and 40-fold for 5'-DFUR. The increase in sensitivity to these pyrimidines of TP-transfected cells significantly correlated with the increase in both TP activity and TP expression. Transfected clone LS174T-c2 but not wild-type cells exhibited formation of [3H]FdUMP from [3H]5-FU. In addition the LS174T-c2 clone enhanced the cytotoxic effect of 5'-DFUR, but also that of 5-FU, towards co-cultured parental cells. For both anti-cancer agents, this bystander effect did not require cell-cell contact. These results show that both 5-FU or 5'-DFUR could be used together with a TP-suicide vector in cancer gene therapy.
5-氟尿嘧啶(5-FU)和5-氟尿嘧啶的前体药物5'-脱氧-5-氟尿苷(5'-DFUR)是由胸苷磷酸化酶(TP)激活的抗癌剂。将人TP cDNA转染到癌细胞中以使它们对这些嘧啶抗代谢物敏感,可能是人类癌症基因治疗研究中的一种重要方法。在本研究中,将含有人类TP cDNA的表达载体(pcTP5)转染到LS174T人结肠癌细胞中。随机选择并分析了八个稳定转染子。与野生型细胞相比,TP转染细胞中5-FU和5'-DFUR的细胞毒性作用更高。5-FU的IC50最大降低了80倍,5'-DFUR降低了40倍。TP转染细胞对这些嘧啶敏感性的增加与TP活性和TP表达的增加显著相关。转染克隆LS174T-c2而非野生型细胞能从[3H]5-FU形成[3H]FdUMP。此外,LS174T-c2克隆增强了5'-DFUR对共培养亲本细胞的细胞毒性作用,也增强了5-FU的细胞毒性作用。对于这两种抗癌剂,这种旁观者效应不需要细胞间接触。这些结果表明,5-FU或5'-DFUR均可与TP自杀载体一起用于癌症基因治疗。